A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations – results of a prematurely terminated study
Studies have suggested the reduced effectiveness of vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections with high vancomycin minimum inhibitory concentrations. Alternative...
Source: Trials - Category: General Medicine Authors: Shirin Kalimuddin, Yvonne F. Z. Chan, Rachel Phillips, Siew Pei Ong, Sophia Archuleta, David Chien Lye, Thuan Tong Tan and Jenny G. H. Low Tags: Research Source Type: research
More News: Cubicin | General Medicine | Infectious Diseases | MRSA | Staphylococcus Aureus | Study | Superbugs